|4Jul 26, 11:38 AM ET

Bankier Alain D 4

4 · Intiva BioPharma Inc. · Filed Jul 26, 2018

Insider Transaction Report

Form 4
Period: 2018-07-25
Transactions
  • Award

    Stock option - right to buy

    2018-07-25+840,000840,000 total
    Exercise: $0.54From: 2018-07-25Exp: 2025-07-25Common Stock (840,000 underlying)
  • Award

    Stock option - right to buy

    2018-07-25+100,000100,000 total
    Exercise: $0.54From: 2018-07-25Exp: 2025-07-25Common Stock (100,000 underlying)
Holdings
  • Class C Warrants (right to buy)

    Exercise: $0.50From: 2017-11-29Exp: 2018-07-27Common Stock (28,000 underlying)
    28,000
  • Common Stock

    2,256,000
Footnotes (3)
  • [F1]70,000 options vested immediately, with the remainder vesting monthly over the next 11 months beginning August 1, 2018.
  • [F2]Granted under the Company's 2018 Equity Incentive Plan.
  • [F3]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.

Documents

1 file
  • 4
    marketforms-42445.xmlPrimary

    PRIMARY DOCUMENT